No Data
Why Jilin Jian Yisheng Pharmaceutical's (SZSE:002566) Shaky Earnings Are Just The Beginning Of Its Problems
Yisheng Pharmaceutical: Report for the third quarter of 2024
jilin jian yisheng pharmaceutical (002566.SZ): The net income in the first three quarters was 35.8648 million yuan, a decrease of 38.66% year-on-year.
Yisheng Pharmaceutical (002566.SZ) announced its third quarter report on October 25th. In the first three quarters of 2024, the company achieved a revenue of 0.506 billion yuan, a decrease of 22.36% year-on-year; net income attributable to the shareholders of the listed company was 35.8648 million yuan, a decrease of 38.66% year-on-year; net income after deducting non-recurring gains and losses was 20.1981 million yuan, a decrease of 54.55% year-on-year; basic earnings per share were 0.1084 yuan per share.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) released its performance for the first three quarters, with net income of 35.8648 million yuan, a year-on-year decrease of 38.66%.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Jilin Jian Yisheng Pharmaceutical: Half-year report for the year 2024.
Jilin Jian Yisheng Pharmaceutical: Summary of Half-Year Report in 2024.
Some Confidence Is Lacking In Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SZSE:002566) As Shares Slide 25%
